【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Product Profiles
04.1.1 Iressa
04.1.2 Abraxane
04.1.3 Alimta
04.1.4 Gemzar
04.1.5 Xalkori
04.1.6 Avastin
04.1.7 Tarceva
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Molecule Type
08.1 Biologics
08.2 Small Molecules
09. Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 AstraZeneca
18.3.1 Iressa
18.4 Celgene
18.4.1 Abraxane
18.5 Eli Lilly
18.5.1 Alimta
18.5.2 Gemzar
18.6 Pfizer
18.6.1 Xalkori
18.7 Roche
18.7.1 Avastin
18.7.2 Tarceva
18.8 Other Prominent Vendors
19. Pipeline Portfolio
20. Key Vendor Analysis
20.1 AstraZeneca plc
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Revenue by Business Segmentation
20.1.6 Revenue Comparison 2011-2013
20.1.7 Sales Revenue by Geographical Segmentation
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Celgene
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Strategy
20.2.4 Business Segmentation by Revenue 2011-2013
20.2.5 Sales by Geography
20.2.6 Key Developments
20.2.7 SWOT Analysis
20.3 Eli Lilly
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue 2013
20.3.4 Business Segmentation by Revenue 2012 and 2013
20.3.5 Sales by Geography
20.3.6 Business Strategy
20.3.7 Key Developments
20.3.8 SWOT Analysis
20.4 Pfizer
20.4.1 Key Facts
20.4.2 Business Description
20.4.3 Business Segmentation
20.4.4 Revenue by Business Segmentation
20.4.5 Revenue Comparison 2012 and 2013
20.4.6 Sales by Geography
20.4.7 Business Strategy
20.4.8 Key Developments
20.4.9 SWOT Analysis
20.5 Roche
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Business Segmentation by Revenue 2013
20.5.4 Business Segmentation by Revenue 2012 and 2013
20.5.5 Geographical Segmentation by Revenue 2013
20.5.6 Business Strategy
20.5.7 Recent Developments
20.5.8 SWOT Analysis
21. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Non-Small-Cell Lung Cancer Market 2013-2018 (US$ billion)
Exhibit 3: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type
Exhibit 4: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type 2013
Exhibit 5: Global Non-Small-Cell Lung Cancer Market Segmentation by Route of Administration
Exhibit 6: Global Non-Small-Cell Lung Cancer Market Segmentation by Route of Administration 2013
Exhibit 7: Global Non-Small-Cell Lung Cancer Market by Geographical Segmentation 2013
Exhibit 8: Global Non-Small-Cell Lung Cancer Market Share Analysis 2013
Exhibit 9: Sales Comparison of Major Drugs 2010-2013 (US$ million)
Exhibit 10: AstraZeneca’s Iressa Sales Comparison 2006-2013 (US$ million)
Exhibit 11: Iressa Sales Comparison in Western Europe 2009-2013 (US$ million)
Exhibit 12: Iressa Sales Comparison in the Established ROW 2009-2013 (US$ million)
Exhibit 13: Iressa Sales Comparison in the Emerging Markets 2009-2013 (US$ million)
Exhibit 14: Region-wise Total Sales Comparison of Iressa 2009-2011 (US$ million)
Exhibit 15: Sales Comparison of Abraxane 2009-2013 (in US$ million)
Exhibit 16: Sales Comparison of Alimta 2003-2011 in the US (US$ million)
Exhibit 17: Sales Comparison of Alimta 2003-2011 Outside the US (US$ million)
Exhibit 18: Total Sales Comparison of Alimta 2003-2011 (US$ million)
Exhibit 19: Region-wise Total Sales Comparison of Alimta 2003-2011 (US$ million)
Exhibit 20: Sales Comparison of Gemzar in the US 2003-2011 (US$ million)
Exhibit 21: Sales Comparison of Gemzar Outside the US 2003-2011 (US$ million)
Exhibit 22: Worldwide Total Sales Comparison of Gemzar 2003-2011 (US$ million)
Exhibit 23: Region-wise Total Sales Comparison of Gemzar 2003-2011 (US$ million)
Exhibit 24: Sales Forecast of Xalkori 2013-2018 (US$ million)
Exhibit 25: Sales Comparison of Avastin and Tarceva 2005-2013 (in US$ million)
Exhibit 26: Sales Comparison of Avastin 2005-2013 (US$ million)
Exhibit 27: Sales Comparison of Tarceva 2005-2013 (US$ million)
Exhibit 28: Late Stage Pipeline Molecules for Non-Small-Cell-Lung Cancer
Exhibit 29: AstraZeneca plc: Business Segmentation
Exhibit 30: AstraZeneca plc: Revenue by Business Segmentation2013
Exhibit 31: AstraZeneca plc: Revenue by Business Segmentation 2011-2013 (US$ billion)
Exhibit 32: AstraZeneca plc: Sales Revenue by Geographical Segmentation 2013
Exhibit 33: Celgene Corp.: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 34: Celgene Corp.: Sales by Geography 2013
Exhibit 35: Eli Lilly and Co.: Business Segmentation by Revenue 2013
Exhibit 36: Eli Lilly and Co.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 37: Eli Lilly and Co.: Sales by Geography 2013
Exhibit 38: Pfizer Inc.: Business Segmentation
Exhibit 39: Pfizer Inc.: Revenue by Business Segmentation 2013
Exhibit 40: Pfizer Inc.: Revenue by Business Segmentation 2012 and 2013
Exhibit 41: Pfizer Inc.: Revenue by Geography 2013
Exhibit 42: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 43: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 44: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals Division)
Exhibit 45: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics Division)
【レポート販売概要】
■ タイトル：世界の非小細胞肺癌(NSCLC)治療市場：生物学的製剤、分子標的治療■ 英文：Global Non-small Cell Lung Cancer Market 2014-2018
■ 発行日：2014年9月10日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4123
■ 調査対象地域：グローバル
- DRaaS（クラウド式災害復旧サービス）の世界市場：バックアップ、リアルタイム複製、データセキュリティ、プロフェッショナルサービスMarketsandMarkets forecasts the Disaster Recovery as a Service (DRaaS) market size to grow from USD 1.68 Billion in 2016 to USD 11.11 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 45.9% from 2016 to 2021. Faster data recovery, cost-effectiveness, greater flexibility, automation capabilities, and simple testing features of DR services are the key factors driving the growth of the Disa …
- 顧客関係管理（CRM）の世界市場分析：展開別、企業規模別、用途別（BFSI、小売、ヘルスケア、テレコム＆IT、ディスクリート型製造）、地域別、セグメント予測、2014-2025The global customer relationship management market is expected to reach USD 81.9 billion by 2025, according to a new report by Grand View Research, Inc. The ability of CRM suites to carry out business with ease is driving the demand for the CRM solution across both big and small companies. Customer relationship management solutions have managed to exhibit an impressive adoption and growth rate in …
- MIM-D3 (Dry Eye Syndrome)：市場予測と分析（～2022）MIM-D3 (Dry Eye Syndrome) - Forecast and Market Analysis to 2022 Summary Dry eye syndrome (DES), or keratoconjunctivitis sicca, is a multifactorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. DES, which is often referred to simply as dry eye, is the most prevalent form of ocular discomfort and irritation. The most common symptoms of DES are …
- RSウイルス感染症治療薬の世界市場2016-2020About Human Respiratory Syncytial Virus Drugs Respiratory syncytial virus (RSV) is a virus that leads to infections in the lungs and the respiratory tract. It commonly affects most children in the ages 2 or below. RSV can also infect adults. In adults and the older population, the symptoms of RSV are mild and similar to that of common cold. Infection with RSV can be severe in certain cases, partic …
- 通気性抗菌コーティングの世界市場分析：用途別（室内空気環境、金型の修復、テキスタイル、医療･製薬、建設、食品）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、RoW）、セグメント予測、2014 – 2025The global breathable antimicrobial coatings market is expected to reach USD 676.7 million by 2024, according to a new report by Grand View Research, Inc. Growing population and high focus towards better healthcare services are expected to fuel the demand over the forecast period. In addition, supportive government regulations and increasing medical device & pharmaceutical manufacturing in develop …
- グリオキサールの世界市場分析：用途別（繊維、皮革、樹脂・ポリマー、化粧品、製紙包装、石油・ガス）、セグメント予測The global glyoxal market is expected to reach USD 2.60 billion by 2024, according to a new report by Grand View Research, Inc. Increasing oil & gas exploration and production activities in Asia Pacific and the Middle East are anticipated to drive global market. Global glyoxal industry is expected to witness a significant growth over the forecast period on account of its wide application scope acr …
- 世界の送電・配電市場：インフラ、プロジェクト、投資、主要事業者Global Transmission and Distribution Report - Infrastructure, Upcoming Projects, Investments, Key Operators and Analysis to 2020 Summary “Global Transmission and Distribution Report - Infrastructure, Upcoming Projects, Investments, Key Operators and Analysis to 2020” is the latest report from GlobalData, the industry analysis specialists that offers information and a comprehensive understanding of …
- Idiopathic Pulmonary Fibrosis：グローバル臨床試験レビューH2, 2013Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2013" provides data on the Idiopathic Pulmonary Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Idiopathic Pulmonary Fibrosis. It includes an overv …
- 産業用コントロールバルブの世界市場：スライディングステム調節弁、回転シャフト調節弁About Industrial Control Valves Industrial control valves are devices that are used to regulate the flow of fluids and gases. They are also used to regulate pressure within the system. Control valves monitor flow, temperature, and pressure by utilizing signals and partially or fully open or close as per the requirement. Sensors provide changes in conditions which are then compared to a set point. …
- キサンタンガムの世界市場予測（～2022年）The xanthan gum market is projected to grow at a CAGR of 3.25% from 2016 to 2022, to reach a projected value of USD 452.8 Million by 2022. Xanthan gum has become prominent in the recent years, due to the increase in the demand for various gluten-free and natural food & beverage products. Also, the growth in inclination of consumers toward convenience food is fueling the demand for xanthan gum, as …
- German Hospital Clinical Chemistry and Immunodiagnostics Market 2014This new report from Venture Planning Group contains 523 pages, 64 tables, and presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with sign …
- Workspace-as-a-Service（WaaS）ベンダー比較Workspace-as-a-Service (WaaS) is a blend of unified managed services delivered to enhance and automate the delivery of applications and data across multiple personalized devices without threatening the security of the data or the device itself. Furthermore, increase in proliferation of portable devices in enterprise and dependency of enterprise class applications is driving the need for deployment …
- 世界の経腸栄養補給装置動向（2012-2016）TechNavio's analysts forecast the Global Enteral Feeding Devices market to grow at a CAGR of 6.23 percent over the period 2012- 2016. One of the key factors contributing to this market growth is the increasing number of preterm births. The Global Enteral Feeding Devices market has also been witnessing the increasing use of low-profile feeding tubes. However, the complications with enteral feeding …
- ブラジル/ロシア/インド/中国の心臓血管モニタリング及び診断装置市場（～2020）BRIC Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020", provides key market data on the BRIC Cardiovascular Monitoring and Diagnostic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), …
- 世界の研磨布紙市場2015The Global Coated Abrasives Industry Report 2015 is a professional and in-depth study on the current state of the Coated Abrasives industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Coated Abrasives market analysis is provided for the international markets including development trends, competitive lan …
